$AYI

ACUITY INC. (DE)

AlphAI earnings readFiscal Q4 2026 and Fiscal 2026 · OCT 1Solid Execution Delivers Net Sales Growth, Improved Operating Performance, and Strong Cash FlowVerdict: solid

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

4
2
0
$22K
$1.2M
O'Shaughnessy Laura
0%
See all $AYI insider activity →
Low

GOLDMAN BARRY R sold $1.2M of AYI

GOLDMAN BARRY R (SVP & General Counsel) sold 3,800 shares of ACUITY INC. (DE) (AYI) at $321.48 ($1.22M total) on 2026-10-27.

Acuity FY 2026: Revenue $4.64B, EPS $17.05— 10-K Summary

Acuity Inc. reported FY 2026 revenue of $4.64B, up 6.8% YoY, with net income rising 34% to $531.3M and EPS increasing 36.1% to $17.05. Growth was driven by Acuity Intelligent Spaces, while Acuity Brands Lighting saw a 1.0% sales decline but improved margins.

AYI sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 6 news stories mentioning AYI (ACUITY INC. (DE)). Coverage has skewed bullish: 4 bullish, 2 neutral, and 0 bearish.

Recent AYI coverage spans earnings, insider activity and mergers & acquisitions.

In the last 30 days, AYI insiders filed 2 SEC Form 4 transactions — 1 purchase ($22K) and 1 sale ($1.2M). The most active reporter was O'Shaughnessy Laura with 1 filing.

What's driving AYI

AlphAI scores every news story that mentions AYI with an AI model for sentiment and relevance, and aggregates insider trades from ACUITY INC. (DE)'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $AYI

Score

AYI Maintained by Oppenheimer -- Price Target Lowered to $415

Oppenheimer maintained an 'Outperform' rating on Acuity Inc (AYI) but lowered its price target from $440 to $415. According to GuruFocus, AYI is undervalued by 7.2% with a GF Value of $323.66. The company has a GF Score of 88/100, indicating strong financial performance. AYI operates in lighting and building management solutions with a market cap of $8.99 billion.

$ACNHighAI 8/10

Company News for Oct 2, 2026

Accenture's (ACN) shares rose 15.8% after beating Q4 earnings estimates. Acuity (AYI) fell 3.4% missing revenue estimates. McKesson (MCK) gained 5.3% after reaffirming fiscal 2027 EPS guidance. Progress Software (PRGS) dropped 8.5% after missing Q3 revenue estimates.

$ACNMed

Stocks making the biggest moves midday: Accenture, Synopsys, United Therapeutics, Vicor and more

Accenture rose 18% after Q4 revenue of $18.7B beat estimates. McCormick's Q3 results topped expectations but shares fell 2% amid Unilever's acquisition. McKesson gained 4% on reaffirmed guidance and a CVS Health partnership. United Therapeutics climbed 6% after a court ruling, while Liquidia dropped 15%. Constellation Energy gained 3% on a 20-year Amazon deal. Synopsys jumped 8% with 2027 revenue targets. Sigma Lithium slid 16% after halting production.

Related tickers